Conclusions. Our study suggests that hypertension has no adverse effect on survival at 2 years in the haemoBackground. Few studies have quantified the effect of hypertension on survival in the haemodialysis (HD) dialysis population. population. We have previously reported lack of Key words: antihypertensives; chronic renal failure; adverse effect of hypertension on 1-year mortality in a end-stage renal disease; haemodialysis; hypertension; cohort of 649 haemodialysis patients (Am J Kidney Dis mortality; survival 1996; 28: 737-744). We report here the effect of hypertension on 2-year survival in the same cohort of patients. Methods. We reviewed the complete computerized files
Introduction
on 649 HD patients enrolled in 10 haemodialysis centres in the state of Mississippi, USA. One-month Recent studies have highlighted the magnitude of dialysis records for each patient from mid-October hypertension in the HD population. The impact of 1994 to mid-November 1994 were reviewed. Predialysis hypertension on mortality in HD patients has, howmean arterial pressure was calculated as immediate ever, not been well studied. Retrospective analyses predialysis diastolic pressure plus one-third the differhave suggested that the key to long-term survival is ence between systolic and diastolic pressure. Patients elimination of hypertension [1, 2] . Charra et a1. [3] were classified as hypertensive if their average prehave found reduced survival when predialysis mean MAP was more than 114 mmHg or they were receiving arterial pressure (pre-MAP) was above 99 mmHg. In antihypertensive drugs during the study period. a previous publication [4] , we have shown that hyperNormotensives had a pre-MAP <114 and were not tension is present in 72% of 649 patients surveyed. We receiving any antihypertensives. We followed these followed these patients longitudinally for 2 years. We patients for 2 years to determine their survival and the have reported earlier on the lack of adverse effects of effect of their BP status, as determined in October hypertension on 1-year mortality in a cohort of 649 1994, on 2-year mortality.
patients [5] . We report here on their survival at 2 years Results. In univariate analysis, hypertension was and its relation to their blood pressures after adjusting associated with improved 2-years survival (relative for age, diabetes mellitus, serum albumin, and race. risk 0.64, P=008 compared to normotensives). Furthermore, among the hypertensives, good blood pressure control ( less than 140/90) was associated with tensives (Normo) had a pre-MAP <114 and were not receiving one antihypertensive drug, calcium-channelreceiving any antihypertensives. Causes of end-stage renal blockers were the most commonly used (in 48% of disease were identified from patient's records as reported by those on one antihypertensive drug) followed by direct the treating nephrologist. Urea reduction ratio is done rou-vasodilators (20%) and sympatholytics (20%). The tinely on our patients and the average of two readings were least used was angiotensin-converting enzyme inhibtaken at baseline. Serum albumin is the average of three itors (in 12% of those on one antihypertensive drug).
readings at baseline. We followed these patients for 2 years to determine their survival and the effect of their BP status, as determined in October 1994, on 2 years mortality.
Univariate analysis: (Table 2)
After 24 months of folllow-up we observed 157 deaths; Statistics 435 patients were alive; 34 patients were lost to follow The unpaired Student t-test was used for comparisons invol-up, and 23 had been transplanted. Live patients were ving only two groups. We used the Cox proportional hazard censored at 24 months, at the time of transplant or model to assess relative risk in both univariate and multivari-loss to follow-up. At the end of 2 years follow-up, ate analyses. Unless otherwise stated, all data are reported there were 57 deaths among the 191 normotensives as the mean±SD and P value <0.05 was considered signi-(29.8%) and 100 deaths among 458 hypertensives ficant. Statview computer software (Abacus Concepts, Inc. (21.8%). Table 2 shows the results of univariate anaBerkeley, CA 1992) was used.
lysis. Gender did not appear to affect survival. Blacks fared better than whites (relative risk of death at 2 years was 0.51, P=0.003). Age was the most important Results factor adversly affecting survival. For each year increase in age, risk of death was increased by 3%. Description of the study population: (Table 1) Albumin also strongly influenced survival. Each 1-g increase in albumin decreased RR 70%, P<0.0001. Demographics, dialysis duration, ranges of blood pressure, and and reported causes of ESRD in the total Diabetes mellitus was associated with an increased relative risk of 1.52, P=0.01. Urea reduction ratio study population as well as in the hypertensives and normotensives are shown in Table 1 . All patients were ( URR) had no influence on survival ( URR<0.65 group had a relative risk of dying of 0.94, P=0.83). dialysed with cuprophane-based dialysers. The average dialysis session was 236 min (approximately 4 h) three There was no difference in survival according to the time on dialysis at baseline ( Table 2) . Hypertensives times a week. The average urea reduction ratio was 0.59. The predialysis MAP was 111±11 mmHg for with an average pre-MAP of 115 mmHg fared better than normotensives (average pre-MAP 101 mmHg); the total population. Four hundred and sixty-seven patients (71.9% of total study population) were hyper-relative risk of dying at 2 years for the hypertensives was 0.64, P=0.008.). Furthermore, among the hypertensive with an average pre-MAP of 115±11 mmHg; 381 (81.5%) of the hypertensives were receiving antihy-tensives, good blood pressure control ( less than 140/90 or pre-MAP <106 mmHg) was associated with pertensive drugs while 86 patients (18.5%) were not; 220 patients (47.1% of the hypertensives) were receiving increased relative risk of death at 2 years (RR 1.86, P=0.004). Patients were then divided into five groups one antihypertensive drug; 132 (28.2%) were receiving two antihypertensive drugs, while 29 patients (or 6.3%) according to their actual level of BP at baseline ( Table 3 ). This classification corresponds to the stages were receiving three or more drugs. Among the group defined by the Joint National Committee on the Prevention and Treatment of Hypertension in its fifth the normotensives that did not reach statistical signireport [6 ] . There was a gradual consistent increase in ficance (RR 0.73, P=0.06). relative risk of dying as the BP increases. The severe hypertensives had the best survival and were used as the reference group. Moderate hypertensives had a RR Discussion of 1.52, mild hypertensives RR 1.71, high normal BP 2.46 and normal BP group 2.59. The reduced RR of Our study agrees with several prior studies [7] showing hypertensives was only true for blacks (Table 4) which increasing age, diabetes mellitus, and low serum albuconstituted the vast majority of our population (89%). min to have an adverse effect on survival in the HD In whites there was an increased risk of dying among population. We have shown in this study that hyperthe hypertensives that did not reach statistical significtensive HD patients have a better 2-year survival than ance (RR 1.4, P=0.44) .
the normotensives. The improved 2-year survival was evident but less significant after adjusting for all other Multivariate analysis: (Table 5) variables that were significant in univaraiate analysis. Most importantly, we did not find any adverse effect In multivariate analysis (similar to univariate analysis), only increasing age and low serum albumin were of high blood pressure on 2-year survival in our cohort of haemodialysis population. The improved survival associated with increased RR of dying. There was a trend towards increased mortality in the diabetics (RR was gradual and consistent as the blood pressure increased at all levels and stages of blood pressure. 1.3, P=0.07). Black race had a favourable effect on survival that was marginally statistically significant There did not appear to be a certain cut-off BP point below which survival decreased. Thus, we do not (RR 0.64, P=0.05). BP was not an independent factor affecting 2-year survival. Indeed there was a reduced believe that the reduced survival of the normotensives is related to an underlying heart failure causing relative relative risk of dying in the hypertensives compared to lowering of the blood pressure and acting as a con-the blood pressure and sympathetic system activation during dialysis. The difference may also relate to length founding variable increasing mortality. Furthermore, of follow up (much longer in Charra's series) and the we used the blood pressure at baseline to avoid the population studied. Most of Charra's patients were pre-terminal lowering of blood pressure in sick patients whites as compared to 89% blacks in the current study. who are slowly deteriorating from underlying cardioIndeed this is supported by our observation that among vascular disease. Similar conclusions were reached in the 66 white patients in our study, there was an increase a recent study by Iskei et a1. [8] who found that the in RR (albeit statistically insignificant) among white lower the diastolic blood pressure, the higher the hypertensives while hypertension in blacks was associmortality, in a group of 1243 haemodialysis patients. ated with reduced mortality. Earlier studies looking at effect of hypertension on survival in the HD population are few. In a recent
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